NSE - Delayed Quote INR

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS)

2,802.70

-113.30

(-3.89%)

At close: 3:30:00 PM GMT+5:30

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for

Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 2 days ago

NEO

GSK
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years

On Wednesday, the Advisory Committee on Immunization Practices (ACIP) voted to expand its recommendation for the use of respiratory syncytial virus (RSV) vaccines approved for adults 50-59 years of age at increased risk of RSV-associated lower respiratory tract disease (LRTD). In June 2024, ACIP postponed a vote on a recommendation for adults aged 50-59 at increased risk for RSV-LRTD until additional data becomes available. The update includes Pfizer Inc.’s (NYSE:PFE) Abrysvo (Respiratory Syncyt

Benzinga 7 days ago

GSK

PFE

MRNA
UK Becomes First Country To Authorize Blenrep In Two Combo Regimens

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday authorized GSK plc’s (NYSE:GSK) Blenrep. Blenrep is approved for the treatment of adults with multiple myeloma in combination with bortezomib plus dexamethasone (BVd) in patients who have received at least one prior therapy, and in combination with pomalidomide plus dexamethasone (BPd) in patients who have received at least one prior therapy including lenalidomide. This U.K. regulatory authorization marks the first

Benzinga 7 days ago

GSK
New Study Shows Shingles Vaccine Linked To 20% Lower Dementia Risk, GSK Stock Pops

Researchers investigated whether the shingles (herpes zoster) vaccine can help prevent dementia. Previous studies suggest that certain herpes viruses may contribute to dementia, and vaccines might have immune benefits. The new research, published on ...

Benzinga 20 days ago

GSK
GSK resolves patent lawsuit against Pfizer over RSV vaccines

(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent rights in its competing RSV shot Arexvy, according to a Thursday filing in Delaware federal court. GSK and Pfizer said in the filing that they would dismiss the case with prejudice, which means it cannot be refiled. GSK, Pfizer and Moderna have developed RSV shots approved by the U.S. Food and Drug Administration, with GSK's Arexvy responsible for the majority of U.S. RSV vaccine sales.

Reuters 21 days ago

GSK

PFE
Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report?

Glaxo (GSK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks 23 days ago

GSK
Is GSK plc (GSK) the Most Undervalued Healthcare Stock to Buy According to Analysts?

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other most undervalued healthcare stocks to buy according to analysts. Rising Healthcare Costs and the Impact of Tariffs on US-China Trade in […]

Insider Monkey 24 days ago

GSK
Is GSK plc (GSK) the Best ADR Stock to Buy According to Hedge Funds?

We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares in foreign companies, allowing American investors […]

Insider Monkey 27 days ago

GSK
Jim Cramer Says ‘Buy and Put Away’ GSK (GSK) for Its 4% Yield

We recently published a list of Jim Cramer Discussed These 6 Stocks Recently. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other stocks that Jim Cramer discussed. On Tuesday, Jim Cramer, host of Mad Money, defended the growing wave of artificial intelligence investment, drawing a distinct […]

Insider Monkey 29 days ago

GSK
Why GSK plc (GSK) Is Among the Most Undervalued Biotech Stocks to Invest In

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other most undervalued biotech stocks to invest in. Trump’s Tariffs and the Pharma Sector On February 21, Jared Holz, Mizuho Securities America’s […]

Insider Monkey last month

GSK
Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant

Pfizer offloads its 7.3% Haleon stake, raising $3.24B as BlackRock emerges as the new top shareholder

GuruFocus.com last month

PFE

HLN

GSK
Jim Cramer Likes This Healthcare Dividend Stock With 4% Yield

We recently published a list of Jim Cramer Was Talking About These 10 Stocks Amid Tariff Chaos. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other stocks that Jim Cramer was talking about amid tariff chaos. Jim Cramer in a latest program on CNBC talked about […]

Insider Monkey last month

GSK
Bear Of The Day: TopBuild (BLD)

HIgh interest rates and sticky inflation have been a source of building companies weakness, will it continue?

Zacks last month

BLD

GSK
Power Players: Meet the women reshaping 10 key European industries

This year, Fortune curated a list of female leaders at the helm of European companies across the continent’s biggest industries.

Fortune last month

GSK

AFLYY
Glaxo (GSK) Up 8% Since Last Earnings Report: Can It Continue?

Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks last month

GSK
Jim Cramer Says GSK plc (GSK) Is A ‘Very Inexpensive Stock With A 4% Yield’

We recently compiled a list of the 10 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks on Jim Cramer’s radar. Jim Cramer, the host of Mad Money, addressed some of Wall Street’s primary concerns on Tuesday, offering insights into […]

Insider Monkey last month

GSK
GSK's Once-Daily Inhalers For Smoker's Lung Has Potential Benefits: Independent Organization Report

The Institute for Clinical and Economic Review (ICER) released a report on Monday assessing the clinical effectiveness and value of GSK Plc's (NYSE:GSK) chronic obstructive pulmonary disease (COPD) treatments, Trelegy Ellipta and Breo Ellipta. Under the Inflation Reduction Act, CMS is negotiating prices for select Medicare Part D drugs. In the current cycle, Trelegy Ellipta and Breo Ellipta are among the medications under review, alongside 15 other drugs slated for pricing changes in 2027. The f

Benzinga last month

GSK
Is GSK plc (GSK) the Best Weight Loss Drug Stock to Buy According to Analysts?

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best weight loss drug stocks to buy according to analysts. Global Surge in Obesity Medication Market Driven by GLP-1 Drugs […]

Insider Monkey last month

GSK
Is GSK plc (GSK) The Best Immunology Stock To Buy Now?

We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best immunology stocks to buy now. The Growing Market for Immune System Treatments Immunology is a rapidly advancing field with significant potential for growth, […]

Insider Monkey last month

GSK
Why GSK plc (GSK) Is One of the Best Vaccine Stocks to Buy According to Hedge Funds

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best vaccine stocks to buy now. What Will Trump’s Tariffs Mean for the Pharma Industry? On February 24, CNBC […]

Insider Monkey last month

GSK

Performance Overview

Return	GLAXO.NS	S&P BSE SENSEX (^BSESN)
YTD	+24.46%	+1.37%
1-Year	+38.01%	+6.56%
3-Year	+91.31%	+40.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS)

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for

US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years

UK Becomes First Country To Authorize Blenrep In Two Combo Regimens

New Study Shows Shingles Vaccine Linked To 20% Lower Dementia Risk, GSK Stock Pops

GSK resolves patent lawsuit against Pfizer over RSV vaccines

Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report?

Is GSK plc (GSK) the Most Undervalued Healthcare Stock to Buy According to Analysts?

Is GSK plc (GSK) the Best ADR Stock to Buy According to Hedge Funds?

Jim Cramer Says ‘Buy and Put Away’ GSK (GSK) for Its 4% Yield

Why GSK plc (GSK) Is Among the Most Undervalued Biotech Stocks to Invest In

Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant

Jim Cramer Likes This Healthcare Dividend Stock With 4% Yield

Bear Of The Day: TopBuild (BLD)

Power Players: Meet the women reshaping 10 key European industries

Glaxo (GSK) Up 8% Since Last Earnings Report: Can It Continue?

Jim Cramer Says GSK plc (GSK) Is A ‘Very Inexpensive Stock With A 4% Yield’

GSK's Once-Daily Inhalers For Smoker's Lung Has Potential Benefits: Independent Organization Report

Is GSK plc (GSK) the Best Weight Loss Drug Stock to Buy According to Analysts?

Is GSK plc (GSK) The Best Immunology Stock To Buy Now?

Why GSK plc (GSK) Is One of the Best Vaccine Stocks to Buy According to Hedge Funds

Performance Overview